---
figid: PMC9353242__ol-24-03-13414-g01
figtitle: Hedgehog signaling regulates the development and treatment of glioblastoma
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Drosophila melanogaster
- Lareunionomyces loeiensis
- Paraechinus aethiopicus
pmcid: PMC9353242
filename: ol-24-03-13414-g01.jpg
figlink: /pmc/articles/PMC9353242/figure/f2-ol-24-03-13414/
number: F2
caption: Related homolog genes (e.g. QKI), transcription factors (e.g. NANOG) and
  sialidase (e.g. NEU4) are able to activate the HH signaling pathway to maintain
  the self-renewal ability of GSCs by increasing SHH/GLI1 expression. ID1 and DLG5
  inhibit cullin-3 ubiquitin ligase, activate HH signaling and promote GSC proliferation
  and tumorigenicity. DRP5 is specifically upregulated in the proneural subtype of
  GSC. NS activates the Wnt and HH signaling pathways by regulating the β/AKT axis
  of β-catenin and Gli1, respectively. Vascular endothelial cells in the tumor microenvironment
  may provide SHH to further activate HH signaling pathways, thereby promoting GSC
  properties. QKI, Quaking homolog; DRP5, dihydro pyrimidine-associated protein 5;
  SHH, Sonic Hedgehog; GBM, glioblastoma; SMO, smoothened; Gli, glioma-associated
  oncogene; GSC, glioblastoma stem cells; ID1, differentiation inhibitor 1; NS, microenvironmental
  nutritional stress; DLG5, discs large homolog 5.
papertitle: Hedgehog signaling regulates the development and treatment of glioblastoma.
reftext: Hongping Wang, et al. Oncol Lett. 2022 Sep;24(3):294.
year: '2022'
doi: 10.3892/ol.2022.13414
journal_title: Oncology Letters
journal_nlm_ta: Oncol Lett
publisher_name: D.A. Spandidos
keywords: Hedgehog | glioblastoma | Sonic | patched-1 | smoothened | drug resistance
  | therapeutics
automl_pathway: 0.9495299
figid_alias: PMC9353242__F2
figtype: Figure
organisms_ner:
- Mus musculus
- Drosophila melanogaster
- Rattus norvegicus
- Homo sapiens
redirect_from: /figures/PMC9353242__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9353242__ol-24-03-13414-g01.html
  '@type': Dataset
  description: Related homolog genes (e.g. QKI), transcription factors (e.g. NANOG)
    and sialidase (e.g. NEU4) are able to activate the HH signaling pathway to maintain
    the self-renewal ability of GSCs by increasing SHH/GLI1 expression. ID1 and DLG5
    inhibit cullin-3 ubiquitin ligase, activate HH signaling and promote GSC proliferation
    and tumorigenicity. DRP5 is specifically upregulated in the proneural subtype
    of GSC. NS activates the Wnt and HH signaling pathways by regulating the β/AKT
    axis of β-catenin and Gli1, respectively. Vascular endothelial cells in the tumor
    microenvironment may provide SHH to further activate HH signaling pathways, thereby
    promoting GSC properties. QKI, Quaking homolog; DRP5, dihydro pyrimidine-associated
    protein 5; SHH, Sonic Hedgehog; GBM, glioblastoma; SMO, smoothened; Gli, glioma-associated
    oncogene; GSC, glioblastoma stem cells; ID1, differentiation inhibitor 1; NS,
    microenvironmental nutritional stress; DLG5, discs large homolog 5.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Nanog
  - Qki
  - Neu4
  - tch
  - Smo
  - Smox
  - Dlg5
  - Gli2
  - Gsc
  - Gli
  - ci
  - Wnt5
  - Wnt4
  - wg
  - Wnt2
  - ths
  - Tch
  - hh
  - smo
  - sm
  - Cul3
  - Gs2
  - Idi
  - Gli1
  - NANOG
  - QKI
  - GLI1
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - NEU4
  - SMO
  - SMOX
  - DLG5
  - GLI2
  - GSC
---
